Delivery Order SPE2DB24D1205-SPE2DB25FCXHT
Award Date
6/3/25
Potential Completion Date
6/25/25
Potential Value
$9.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,131.12, is for the delivery of ZEPZELCA 4 MG VIALS. It is a firm fixed-price delivery order contract with an ultimate completion date of April 29, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of ZEPZELCA 4 MG VIALS. The contract is a Firm Fixed Price type with a ceiling value of $9,025.76 and a period of performance through September 4, 2024. The contract was awarded on August 13, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is the prime contractor for this delivery order. This...
This is a $9,025.76 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ZEPZELCA 4 MG VIALS medical products. The contract has an ultimate completion date of November 5, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for providing a wide range of medical commodities, including prescription drugs,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $95,655.40 firm fixed-price delivery order contract is for the provision of ZEPZELCA 4 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg vials of the cancer drug ZEPZELCA, with a ceiling value of $9,025.76 and an ultimate completion date of September 12, 2024. The contract is a firm fixed-price, delivery order type with no set-aside designation. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen has been awarded...
This federal contract award, valued at $9,565.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,104,438 units of the medication ZEPZELCA 4 MG VIALS. The contract has a firm fixed price pricing type and an ultimate completion date of May 22, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,675.40 Firm Fixed Price Delivery Order contract is for the provision of ZEPZELCA 4 MG VIALS, a specialty cancer medication. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp (ABDC) for the supply of ZEPZELCA 4 MG VIALS. The contract has a ceiling value of $18,051.52 and an ultimate completion date of August 7, 2024. This contract is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, will deliver the specified drug product to support military treatment facilities and other federal healthcare providers...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Zepzelca 4 mg vials, a specialty medication. The contract has a ceiling value of $28,696.68 and a period of performance through February 20, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and has an extensive Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The $9,025.76 firm fixed price delivery order is for the supply of Zepzelca 4 mg vials, a specialty pharmaceutical product. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for...